Sophia Abene

Leveraging Evie Ring technology, the collaboration seeks to enhance understanding and develop strategies for managing these illnesses.

The latest data from the Gonococcal Antimicrobial Susceptibility Surveillance, calls for updated treatment protocols and intensified surveillance measures to address this escalating concern effectively.

With no observed mortality or adverse outcomes, this research sheds light on effective treatments for combating the pandemic in younger populations.

BWC0977 has strong potential to effectively target the priority pathogens needed to address public health concerns.

Brii Biosciences presented new data from Phase 2 trials for chronic hepatitis B at EASL Congress 2024, revealing insights into the efficacy of BRII-179 as botha combined therapy and an additional treatment.

Presented at DDW 2024 by Ken Blount, the effectiveness of live biotherapeutic products in treating recurrent C difficile infections (rCDI), offering insights into microbiota alteration and prospects for management.

Exact estimates of hospitalization and fatality rates for SARS-CoV-2 are rare among populations without previous exposure, particularly within demographic subgroups.

Innovative approach across opioid treatment programs bridges geographical barriers, achieving cure rates, and unlocking health benefits for underserved populations.

Historically, pneumococcal vaccination in adults has been reserved for those at heightened risk, with adults bearing the cost compared to free childhood vaccinations.

The FDA alerts against certain apricot seed products containing amygdalin, a potentially harmful compound, and the CDC highlights Salmonella outbreaks, underlining the necessity for proper hygiene and poultry handling.

FDA approves Moderna's RSV vaccine for seniors, young women struggling with recurrent C difficile over the years, FDA grants Karius test to assist diagnosing infectious diseases, and more this week from Contagion.

CDC has been tracking New York City varicella outbreak among migrants with over 870 cases reported since October 2022.

The link between vancomycin susceptibility and decreasing sustained clinical response in C difficile infections.

While much attention has been focused on the immediate risks of the virus during pregnancy, this study is focused on what happens to pregnant individuals after they have had COVID-19.

While carbapenem-resistant Enterobacterales infections occur less frequently, extended-spectrum beta-lactamase-producing Enterobacterales infections are increasing.

Research reveals a surge in pressure ulcers and in-hospital mortality rates during peak pandemic periods, prompting calls for strategies to safeguard care quality.

This genomic diagnostic tool aims to support diagnosis, particularly in immunocompromised patients by identifying pathogens associated with pneumonia and other lung infections.

Vedanta Biosciences initiates the Phase 3 RESTORATiVE303 clinical trial, marking a pivotal moment in the battle against this recurrent infection.

This week, a strategic approach along with existing treatments aimed at reducing incidence rates and curing people of HCV, advocating Lyme disease research in honor of May being its awareness month, Digestive Disease Week coverage, and more this week from Contagion.

With 9 confirmed cases, recent incidences in schools and in the community, caregivers and individuals should stay informed if symptoms appear.

Recent study examines the relationship between COVID-19 vaccination and post-COVID conditions, shedding light on the potential long-term effects of vaccination.

February through April 2024 Chicago faced a measles outbreak within a migrant shelter, prompting action from the CDC.

This report underscores the increase of STIs alongside the ongoing global epidemics of HIV and viral hepatitis in the Americas and African regions.

Authorized for children in malaria-endemic regions, this vaccine aims to bridge the gap between demand and supply, offering hope against malaria's toll.

During Lyme Disease Awareness Month, advocating for collective action in research, education, and prevention can help tackle the challenges of Lyme disease and promote healthier communities nationwide.

At Digestive Disease Week, Paul Feuerstadt MD, FACG, AGAF and fellow investigators explore the potential impact of non-antibiotic medications on gut health and their association with recurrent CDI.

Recent study sheds light on potential mechanisms underlying severe lung damage in COVID-19 patients.

Efforts among organizations aim to develop innovative vaccine candidates and advancements in the global fight against HIV.

Importance of thorough travel history assessment, consistent surveillance, and outreach efforts to manage malaria morbidity among travelers in the US.

Insights from virologist Erin Sorrell PhD MSc offer perspectives on prevention and response strategies.